Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].

Authors :: Novello S
Torri V
Grohe C
Kurz S
Serke M
Wehler T
Meyer A
Ladage D
Geissler M
Colantonio I
Cauchi C
Stoelben E
Ceribelli A
Kropf-Sanchen C
Valmadre G
Borra G
Schena M
Morabito A
Santo A
Gregorc V
Chiari R
Reck M
Schmid-Bindert G
Folprecht G
Griesinger F
Follador A
Pedrazzoli P
Bearz A
Caffo O
Dickgreber NJ
Irtelli L
Wiest G
Monica V
Porcu L
Manegold C
Scagliotti GV
Source :: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Apr; Vol. 33 (4), pp. 454. Date of Electronic Publication: 2022 Jan 25.
Publication Year :: 2022

Language :: English
ISSN :: 1569-8041
Volume :: 33
Issue :: 4
Database :: MEDLINE
Journal :: Annals of oncology : official journal of the European Society for Medical Oncology
Accession number :: 35086737
Full Text :: https://doi.org/10.1016/j.annonc.2022.01.005

Full Text Access

Tools